CD274 and cancer: PD-L1 expression has been correlated with poor clinical outcomes in different cancers [13–15], such as melanoma, lung, breast, bladder, ovarian, salivary gland carcinomas, gastric cancer, kidney tumors as well as osteosarcoma [5, 16, 17].